Anti-nerve growth factor antibodies for the treatment of low back pain
Expert Review of Clinical Pharmacology pp 1-9; doi:10.1080/17512433.2020.1772052
The publisher has not yet granted permission to display this abstract.
Keywords: monoclonal antibodies / low back pain / chronic pain / Tanezumab / Nerve Growth Factors / Fasinumab
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Expert Review of Clinical Pharmacology" .